Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials - The Wall Street Journal


11/24/2025

Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials  The Wall Street JournalNovo Nordisk shares plunge 9% after Alzheimer's drug trial fails to hit key target  CNBCWeight-loss drugs: What other conditions are they being used and tested for?  ReutersSemaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says  CNNNovo Nordisk’s Ozempic Pill Fails in Long-Shot Alzheimer’s Effort  Bloomberg.com...

Original



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top